<DOC>
	<DOCNO>NCT00941057</DOCNO>
	<brief_summary>Investigation bioequivalence ( BE ) Estradiol Valerate ( EV ) Dienogest ( DNG ) administration one film-coated tablet contain 2 mg Estradiol Valerate , 3 mg Dienogest 0.451 mg Levomefolate calcium compare one film-coated tablet contain 2 mg Estradiol Valerate,3 mg Dienogest.Investigation bioequivalence levomefolate calcium administration one film-coated tablet contain 2 mg Estradiol Valerate , 3 mg Dienogest 0.451 mg Levomefolate calcium compare one film-coated tablet contain 0.451 mg levomefolate calcium</brief_summary>
	<brief_title>Bioequivalence Study : 2 mg Estradiol Valerate ( EV ) 3 mg Dienogest ( DNG ) Without With Levomefolate Calcium</brief_title>
	<detailed_description />
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Healthy postmenopausal woman , age : 4575 year body mass index ≥18 ≤30 kg/m2 . Postmenopausal state reveal : medical history , hormone analysis serum : estradiol ≤20 pg/mL woman &lt; 60 year old : folliclestimulating hormone ≥ 40 IU/L screen Contraindications use combine ( Estradiolvalerate/Dienogest ) contraceptive ( e.g.history venous/arterial thromboembolic disease ) Regular intake medication Clinically relevant finding ( ECG , blood pressure , physical gynaecological examination , laboratory examination ) Smoking</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>